Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Ultrafilter Stories

2014-03-11 16:26:49

RIVER EDGE, N.J., March 11, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration system for the treatment of chronic renal failure patients today provided an update on its operations and strategy. Recent Highlights -- Daron Evans appointed to Board of Directors -- Launched NanoGuard-D and NanoGuard-S ultrafilters for filtration of water...

2014-03-11 16:26:38

RIVER EDGE, N.J, March 11, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor Purification, a wholly owned subsidiary of Cantel Medical Corp., announced today that the companies have signed a non-exclusive distributor agreement to distribute Nephros's dialysis ultrafilters to U.S. and Canadian dialysis clinics. Curtis Weitnauer, President and Chief Executive Officer...

2014-02-12 20:21:55

RIVER EDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant,...

2013-11-29 16:21:34

RIVER EDGE, N.J., Nov. 29, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the appointment of Daron Evans to its Board of Directors. Mr. Evans replaces James S. Scibetta who will be leaving the Board effective December 31, 2013. Mr. Evans was also named a member of the Audit Committee. Mr. Evans is a life sciences executive with over 20 years of...

2013-11-14 16:29:04

RIVER EDGE, N.J., Nov. 14, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30(th) 2013 and that the company entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder. Financial Performance for...

2013-05-08 16:28:24

RIVER EDGE, N.J., May 8, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013. Recent Highlights 42% increase in water filter sales Q1 2013 versus Q1 2012 Received EUR600,000 license payment from Bellco S.r.l Commenced Rights Offering and Temporary Reduction in Exercise Price for March...

2013-02-04 16:26:56

RIVER EDGE, N.J., Feb. 4, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market. "The addition of Nephros...

2013-01-15 16:21:44

RIVER EDGE, N.J., Jan.15, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR600,000 from Bellco S.r.l. under the previously announced license agreement. Under the terms of the license agreement which became effective July 1, 2011, Nephros provided an exclusive license to Bellco S.r.l....

2012-11-08 16:29:08

RIVER EDGE, N.J., Nov. 8, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30, 2012. Recent Highlights Year-to-date ultrafilter sales to our three target markets (Dialysis, Hospital and Military) of over $800,000 vs. approximately $600,000 for full year 2011 First shipment of over...

2012-08-14 10:25:04

RIVER EDGE, N.J., Aug. 14, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, announced today financial results for the three and six months ended June 30, 2012. Recent Highlights Appointed Frank Zumbo, Denise Pappas, and Stephen Bob as Regional Sales Managers to focus on ultrafilters in dialysis and hospital markets New...